European pharmaceutical giants are calling for an increase in pharmaceutical prices to the same level as in the USA.

The CEOs of the two major pharmaceutical giants in Europe, Novartis and Sanofi, stated in an open letter on Wednesday that in order to attract investment, the EU should allow pharmaceutical prices to rise to the levels found in the USA. Pharmaceutical prices in the USA are the highest in the world, often nearly three times that of other developed countries. Novartis CEO Vas Narasimhan and Sanofi CEO Paul Hudson wrote, "Price controls and austerity measures in Europe have reduced the attractiveness of its market." They added, "In the context of declining biopharmaceutical competitiveness in Europe, uncertainty about tariffs further diminishes the motivation to invest in the EU." They believe that EU

Global market reportApr 23 02:58 ET

Roche's Chest Pain Triage Algorithm Receives CE Mark

MT NewswiresApr 23 02:10 ET

Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs

BenzingaApr 22 15:21 ET

Roche will invest 50 billion US dollars in the United States over the next five years to enhance research and production capabilities.

① The Swiss Franc healthcare giant Roche announced plans to invest 50 billion USD in the USA over the next five years, creating over 0.012 million new jobs. ② Roche's investment plan is being carried out against the backdrop of the Trump administration initiating an investigation into imported Pharmaceuticals, which could be a precursor to the USA imposing tariffs on the Industry.

cls.cnApr 22 06:09 ET

Roche's $50 Billion US Investment Commitment Includes New Facilities, 12,000 Jobs, Expanded R&D Hubs As Drug Tariffs Loom

BenzingaApr 22 05:53 ET

J.P. Morgan Sticks to Its Sell Rating for Roche Holding AG (RHHVF)

TipRanksApr 22 05:35 ET · Ratings